AI+智造破局 东北制药数智转型激活发展新动能

Core Insights - The core viewpoint of the articles emphasizes the significant advancements made by Northeast Pharmaceutical in its digital transformation, driven by "Artificial Intelligence+" to enhance production efficiency, optimize operational costs, and strengthen market competitiveness [1][2][3]. Group 1: Production Efficiency - The intelligent upgrade in production has become a key focus for the company to improve quality and efficiency. Northeast Pharmaceutical has built a localized knowledge base using DeepSeek, which allows for rapid fault diagnosis, reducing fault location time by over 80% [1]. - The implementation of AI-powered visual inspection equipment has replaced traditional manual checks, ensuring quality control by automatically identifying and removing non-compliant products, thus enhancing production scalability [2]. Group 2: Cost Optimization - The establishment of an energy monitoring system with over 3,000 data collection points has led to significant cost savings, achieving over 20 million yuan in energy efficiency gains within six months, aligning with green development goals and reducing unit production costs [2]. Group 3: Management Efficiency - The development of a big data analysis platform has broken down data silos across departments, enabling real-time data visualization and decision-making, which has transformed the decision-making process from experience-driven to data-driven [3]. - The company’s digital transformation is not merely a technological upgrade but a comprehensive reconfiguration of the entire pharmaceutical manufacturing value chain, aiming for enhanced operational efficiency, product quality, and cost control [3].